Vital Statistics
2019 – PCI invests in a 30,000 sq. ft. expansion to the PCI Clinical Services facility in Rockford, IL as well as a 70,000 sq. ft. expansion at our Ireland site.
2020 – PCI opens of Biotech Center of Excellence in Philadelphia, PA in Spring 2020.

Number of Employees: 3,500 employees across 8 global locations

Who We Are
PCI Pharma Services is an integrated full service provider, a proven and trusted partner to leading companies in the global healthcare industry. We offer unparalleled expertise and experience in taking compounds from the earliest stages of development through to successful commercialization, delivering speed-to-market and commercial success for our customers.

Our core services support each stage of the product lifecycle, including drug development, clinical trial supply, commercial launch and ongoing commercial supply. We partner with clients in providing innovative technologies, flexible solutions, and an integrated supply network supporting lifesaving medicines destined to over 100 countries around the world.

We support clients with a dedication to providing the industry’s leading experience, exemplified in our operational flexibility, delivery, commitment to safety, supported by industry leading technologies and an exemplary quality and regulatory record. This has allowed us to be the partner of choice for leading pharmaceutical companies around the world, operating as a seamless extension of their business.

Major Markets
PCI provides Drug development, Clinical trial services, as well as Commercial manufacturing and packaging services for brand and generic pharmaceuticals, biotech, device, over-the-counter pharmaceuticals, animal health, and consumer healthcare/beauty. Our state-of-the-art cGMP facilities feature site segregation for Schedule II – V Controlled Substances, Animal Health, Hormonal Products, Penicillin Products, Cytotoxins, and Potent Compounds. We support Cold Chain requirements including controlled ambient / CRT: 15-25°C, 2-8°C, -20ºC, -40°C, -80ºC, and -196°C for Advanced Therapeutic Medicinal Products (ATMP).

Services Offered
Drug Development:
PCI offers full service Formulation Development including Analytical Development/Characterization and Xcelodose ® product-in-capsule delivery for early phase clinical trials, as well as an extensive array of sterile and nonsterile delivery forms for early phase studies.

Clinical Trial Services:
PCI supports investigational medicines with Tablet, Capsule, Powder and Liquids Manufacturing, Analytical Development, Stability Testing, Clinical Packaging and Labeling including product Blinding and Randomization, Global Storage and Distribution, as well as Returns Management and Destruction.

Commercial Services:
PCI supports commercial product manufacturing including Commercial scale-up and large-scale manufacturing. Investments include separate suites for large volume tablets manufacture plus roller compaction technology for heat and moisture sensitive formulations. We offer Packaging Services for a broad range of delivery forms including Oral Solids, Powders, Liquids, Creams and Gels, as well as Injectable and Parenteral Delivery forms including Device Assembly. In support of commercial supply we offer Analytical Testing and Stability services.

Serialization and Anti-counterfeiting:
PCI is leading the global market in Serialization and Anticounterfeiting, having invested in leading technologies and providing commercial serialized product for over six years supporting medicines destined to established and emerging markets. PCI recently celebrated installation of its 80th Serialization line.

Potent Compounds:
PCI provides manufacturing and packaging services for clinical and commercial medicines. PCI features a state-of-the-art, purpose-built, contained manufacturing site for potent compounds with OEL’s down to 0.01μg/m3. This facility was recognized by ISPE as a Facility of the Year in 2014. Potent compound manufacturing is further supported by segregated, purpose-built packaging facilities in both Europe and North America.